Catalysts for Novo Nordisk AS

Novo Nordisk AS — cagrilintide hydrochloride (Phase I Trial Initiation)

Novo Nordisk AS — zalfermin (Phase II Trial Initiation)

WEGOVY (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

Harbin Jixianglong Biotech Co., Ltd. recall (Cls II)

Harbin Jixianglong Biotech Co., Ltd. recall (Cls II)

WEGOVY (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

OZEMPIC (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

ProRx LLC recall (Cls II)

ProRx LLC recall (Cls II)

ProRx LLC recall (Cls II)

ProRx LLC recall (Cls II)

ProRx LLC recall (Cls II)

ProRx LLC recall (Cls II)

OZEMPIC (SEMAGLUTIDE) — FDA approval

OZEMPIC (SEMAGLUTIDE) — FDA approval

OZEMPIC (SEMAGLUTIDE) — FDA approval

GenoGenix LLC recall (Cls II)

GenoGenix LLC recall (Cls II)

OZEMPIC (SEMAGLUTIDE) — FDA approval

OZEMPIC (SEMAGLUTIDE) — FDA approval

WEGOVY (SEMAGLUTIDE) — FDA approval

Boothwyn Pharmacy LLC recall (Cls II)

Boothwyn Pharmacy LLC recall (Cls II)

Boothwyn Pharmacy LLC recall (Cls II)